Explore
Validate
Learn
ImmunohistochemistryAntibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN196823 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Ataxia Telangiectasia Mutated (ATM) (pSer1981) antibody
- Antibody type
- Polyclonal
- Description
- Immunoaffinity chromatography.
- Reactivity
- Human
- Host
- Rabbit
- Epitope
- pSer1981
- Vial size
- 50 μL
- Storage
- Store the antibody (in aliquots) at -20°C.
- Handling
- Avoid repeated freezing and thawing.
Submitted references Involvement of human MOF in ATM function.
Human Rif1, ortholog of a yeast telomeric protein, is regulated by ATM and 53BP1 and functions in the S-phase checkpoint.
The ATM-related Tel1 protein of Saccharomyces cerevisiae controls a checkpoint response following phleomycin treatment.
Workshop on The Epidemiology of the ATM Gene: Impact on Breast Cancer Risk and Treatment, Present Status and Future Focus, Lillehammer, Norway, 29 June 2002.
Gupta A, Sharma GG, Young CS, Agarwal M, Smith ER, Paull TT, Lucchesi JC, Khanna KK, Ludwig T, Pandita TK
Molecular and cellular biology 2005 Jun;25(12):5292-305
Molecular and cellular biology 2005 Jun;25(12):5292-305
Human Rif1, ortholog of a yeast telomeric protein, is regulated by ATM and 53BP1 and functions in the S-phase checkpoint.
Silverman J, Takai H, Buonomo SB, Eisenhaber F, de Lange T
Genes & development 2004 Sep 1;18(17):2108-19
Genes & development 2004 Sep 1;18(17):2108-19
The ATM-related Tel1 protein of Saccharomyces cerevisiae controls a checkpoint response following phleomycin treatment.
Nakada D, Shimomura T, Matsumoto K, Sugimoto K
Nucleic acids research 2003 Mar 15;31(6):1715-24
Nucleic acids research 2003 Mar 15;31(6):1715-24
Workshop on The Epidemiology of the ATM Gene: Impact on Breast Cancer Risk and Treatment, Present Status and Future Focus, Lillehammer, Norway, 29 June 2002.
Bernstein JL, Seminara D, Børresen-Dale AL
Breast cancer research : BCR 2002;4(6):249-52
Breast cancer research : BCR 2002;4(6):249-52
No comments: Submit comment
No validations: Submit validation data